INTERVIEW: Life Tech still on the lookout for partnerships and acquisitions
This article was originally published in Clinica
Executive Summary
Thermo Fisher’s $13.6bn acquisition of biotech company Life Technologies was marked as the biggest M&A deal in 2013. The transaction took nearly ten months to clear all the regulatory hurdles before it was completed in February this year, and integration of Thermo’s existing biosciences businesses into Life Technologies is now well underway.